A

Arvinas
D

ARVN

6.51000
USD
0.05
(0.77%)
مغلق
حجم التداول
46,121
الربح لكل سهم
-0
العائد الربحي
-
P/E
-10
حجم السوق
475,173,949
أصول ذات صلة
BNTX
BNTX
-0.380
(-0.38%)
98.700 USD
C
CRSP
-0.760
(-2.02%)
36.850 USD
F
FATE
-0.02000
(-1.68%)
1.17000 USD
G
GH
0.910
(2.45%)
38.000 USD
GSK
GSK
-0.560
(-1.43%)
38.690 USD
MRNA
MRNA
-0.820
(-3.03%)
26.280 USD
PFE
PFE
0.110
(0.47%)
23.330 USD
T
TDOC
-0.09000
(-1.31%)
6.80000 USD
VRTX
VRTX
1.79
(0.41%)
435.79 USD
المزيد
الأخبار المقالات

العنوان: Arvinas

القطاع: Healthcare
الصناعة: Biotechnology
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.